2-(nitrooxy)ethyl apovincaminate has been researched along with cyclic gmp in 1 studies
| Studies (2-(nitrooxy)ethyl apovincaminate) | Trials (2-(nitrooxy)ethyl apovincaminate) | Recent Studies (post-2010) (2-(nitrooxy)ethyl apovincaminate) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 20 | 1 | 1 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | 2-(nitrooxy)ethyl apovincaminate (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, N; Muramatsu, M; Okuyama, S; Otomo, S; Tanaka, M; Tsuchida, K; Yamaura, H | 1 |
1 other study(ies) available for 2-(nitrooxy)ethyl apovincaminate and cyclic gmp
| Article | Year |
|---|---|
Effects of VA-045, a novel apovincaminic acid derivative, on isolated blood vessels: cerebroarterial selectivity.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aorta; Basilar Artery; Blood Vessels; Cerebral Arteries; Coronary Vessels; Cyclic GMP; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rats; Rats, Wistar; Sensitivity and Specificity; Vasodilator Agents; Vinca Alkaloids | 1993 |